Challenge
Both startups and corporates face the same trap: deep tech doesn’t play by lean rules.
​
‣ Startups often collapse because investors expect SaaS-style growth while scientific validation takes years. The result: 92% never reach commercialization.
‣ Corporates invest heavily in pilots or corporate innovation programs, but two out of three fail to hit scope, time, or budget.
‣ Both sides suffer when technologies are forced into premature scaling, or when funding is structured around financial milestones instead of scientific ones.
Current System Limitations
‣ Accelerators and networks create visibility,
but don’t provide the long-term capital architecture needed to industrialize technologies.
‣ Traditional consultants apply valuation-driven or finance-only logic,
ignoring TRL readiness and industry integration.
‣ Corporate venture programs often pursue PR-driven innovation,
yet most pilots never leave the sandbox.
The result:
startups remain “grant-dependent research projects,”
while corporates fail to secure reliable innovation pipelines.
Our Reponse
Arise Innovations bridges science, capital, and industry —
for both venture builders and corporates seeking to adopt or integrate deep tech.
Whether you’re building from scratch or seeking reliable innovation pipelines — we make deep tech fundable, scalable, and adoptable.
​
​
​
​
​
‣ Get a tailored analysis of your funding or innovation gaps
‣ Receive a clear, TRL-aligned roadmap with next steps
‣ Secure your position before the Valley of Death closes in